Inge Grundke-Iqbal, PhD
Affiliations: | Neurochemistry | New York State Institute Basic Research in Developmental Disabilities, NY, United States |
Area:
Alzheimer diseaseGoogle:
"Inge Grundke-Iqbal"Bio:
http://www.researchprofiles.collexis.com/jad/expert.asp?u_id=90
http://www.biomedexperts.com/Profile.bme/500032/Inge_Grundke-Iqbal
Cross-listing: Neurotree - Neuropathology Tree
Collaborators
Sign in to add collaborator
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Wang X, Blanchard J, Grundke-Iqbal I, et al. (2015) Memantine Attenuates Alzheimer's Disease-Like Pathology and Cognitive Impairment. Plos One. 10: e0145441 |
Kazim SF, Cardenas-Aguayo Mdel C, Arif M, et al. (2015) Sera from children with autism induce autistic features which can be rescued with a CNTF small peptide mimetic in rats. Plos One. 10: e0118627 |
Wang X, Blanchard J, Tung YC, et al. (2015) Inhibition of Protein Phosphatase-2A (PP2A) by I1PP2A Leads to Hyperphosphorylation of Tau, Neurodegeneration, and Cognitive Impairment in Rats. Journal of Alzheimer's Disease : Jad. 45: 423-35 |
Dai CL, Chen X, Kazim SF, et al. (2015) Passive immunization targeting the N-terminal projection domain of tau decreases tau pathology and improves cognition in a transgenic mouse model of Alzheimer disease and tauopathies. Journal of Neural Transmission (Vienna, Austria : 1996). 122: 607-17 |
Arif M, Wei J, Zhang Q, et al. (2014) Cytoplasmic retention of protein phosphatase 2A inhibitor 2 (I2PP2A) induces Alzheimer-like abnormal hyperphosphorylation of Tau. The Journal of Biological Chemistry. 289: 27677-91 |
Arif M, Kazim SF, Grundke-Iqbal I, et al. (2014) Tau pathology involves protein phosphatase 2A in parkinsonism-dementia of Guam. Proceedings of the National Academy of Sciences of the United States of America. 111: 1144-9 |
Wang X, Blanchard J, Grundke-Iqbal I, et al. (2014) Alzheimer disease and amyotrophic lateral sclerosis: an etiopathogenic connection. Acta Neuropathologica. 127: 243-56 |
Basurto-Islas G, Grundke-Iqbal I, Tung YC, et al. (2013) Activation of asparaginyl endopeptidase leads to Tau hyperphosphorylation in Alzheimer disease. The Journal of Biological Chemistry. 288: 17495-507 |
Jin N, Qian W, Yin X, et al. (2013) CREB regulates the expression of neuronal glucose transporter 3: a possible mechanism related to impaired brain glucose uptake in Alzheimer's disease. Nucleic Acids Research. 41: 3240-56 |
Cardenas-Aguayo Mdel C, Kazim SF, Grundke-Iqbal I, et al. (2013) Neurogenic and neurotrophic effects of BDNF peptides in mouse hippocampal primary neuronal cell cultures. Plos One. 8: e53596 |